AWM
TMO icon

Altavista Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Altavista Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2.56M Buy
3,838
+180
+5% +$112K 0.52% 41
2021
Q3 		$2.09M Sell
3,658
-111
-3% -$60.9K 0.46% 46
2021
Q2 		$1.9M Buy
3,769
+30
+0.8% +$14.2K 0.41% 49
2021
Q1 		$1.71M Sell
3,739
-30
-0.8% -$14.3K 0.42% 51
2020
Q4 		$1.76M Sell
3,769
-128
-3% -$60K 0.45% 50
2020
Q3 		$1.72M Sell
3,897
-87
-2% -$35.9K 0.47% 49
2020
Q2 		$1.44M Sell
3,984
-205
-5% -$68.7K 0.42% 54
2020
Q1 		$1.19M Buy
4,189
+640
+18% +$202K 0.41% 52
2019
Q4 		$1.15M Sell
3,549
-190
-5% -$57.6K 0.34% 62
2019
Q3 		$1.09M Buy
3,739
+50
+1% +$14.3K 0.34% 63
2019
Q2 		$1.08M Buy
3,689
+485
+15% +$134K 0.35% 63
2019
Q1 		$877K Buy
3,204
+475
+17% +$118K 0.31% 72
2018
Q4 		$611K Buy
2,729
+500
+22% +$117K 0.25% 87
2018
Q3 		$544K Buy
+2,229
New +$513K 0.2% 92

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altavista Wealth Management's TMO Position: Q4 2021 in Review

Altavista Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 4.9% in Q4 2021, buying an estimated $112K and bringing the position to 3,838 shares worth $2.56M. The position accounts for 0.52% of the portfolio, ranked #41.

Altavista Wealth Management first reported a position in TMO in Q3 2018 and has held it in 14 quarters since. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Altavista Wealth Management held 3,838 shares of Thermo Fisher Scientific worth $2.56M as of Q4 2021.
  • Altavista Wealth Management bought 180 Thermo Fisher Scientific shares in Q4 2021, an estimated $112K.
  • Thermo Fisher Scientific made up 0.52% of Altavista Wealth Management's portfolio in Q4 2021, its #41 holding.
  • Altavista Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 14 quarters since.
  • 2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.